BIOXYTRAN, INC (BIXT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-80K 0 80K 160K 240K Q2 '13: 98.9K Q3 '13: 55.7K Q4 '13: 148.4K Q1 '14: 208.4K Q1 '14: 208.4K Q2 '14: 37.8K Q3 '14: 41.5K Q4 '14: -12.1K Q1 '15: 62.5K Q2 '15: 59.4K Q3 '15: 110.8K Q4 '15: 23.2K Q1 '16: 31.5K Q2 '16: 55.6K Q3 '16: 101.1K Q4 '16: 58.2K Q1 '17: 7.4K Q2 '17: 39.5K Q1 '18: 13.3K Q2 '18: 20.3K Q3 '13 Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q2 '18

Gross Profit Quarterly

-60K 0 60K 120K 180K Q3 '13: 14.5K Q4 '13: 69.2K Q1 '14: 154.2K Q1 '14: 154.2K Q2 '14: 25.8K Q3 '14: 7.2K Q1 '15: 47.9K Q2 '15: 44.7K Q3 '15: 43K Q4 '15: -4.8K Q1 '16: 14.7K Q2 '16: 36.8K Q3 '16: 62.9K Q4 '16: 35.7K Q1 '17: -6.2K Q2 '17: 20.1K Q3 '17: 80.1K Q4 '17: -6.8K Q1 '18: -1.9K Q2 '18: 12.2K Q4 '13 Q2 '14 Q2 '15 Q1 '16 Q4 '16 Q3 '17 Q2 '18

Operating Income Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q3 '21: -547.2K Q4 '21: -936K Q1 '22: -819.1K Q2 '22: -537.2K Q3 '22: 14.2K Q4 '22: -1.1M Q1 '23: -750.2K Q2 '23: -1.1M Q3 '23: -985.5K Q4 '23: -1M Q1 '24: -779.2K Q2 '24: -609.3K Q3 '24: -346.2K Q4 '24: -488.3K Q1 '25: -515.1K Q2 '25: -224.1K Q3 '25: -496K Q4 '25: -607.3K Q1 '26: -1.9M Q2 '26: -654.6K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q3 '21: -475.2K Q4 '21: -1M Q1 '22: -912.3K Q2 '22: -622.3K Q3 '22: -123.6K Q4 '22: -814.9K Q1 '23: -785.1K Q2 '23: -1.4M Q3 '23: -1.1M Q4 '23: -1.1M Q1 '24: -560.5K Q2 '24: -661.6K Q3 '24: -392.4K Q4 '24: -752.1K Q1 '25: -1.4M Q2 '25: 35.4K Q3 '25: -282.7K Q4 '25: -522.2K Q1 '26: -2.1M Q2 '26: -619.9K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 7K 14K 21K Q2 '17: 19.4K Q2 '18: 8.1K Q2 '17 Q2 '18

Operating Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q3 '21: -144K Q4 '21: -143.7K Q1 '22: -691.4K Q2 '22: -238.8K Q3 '22: -718.8K Q4 '22: -154.7K Q1 '23: -186.9K Q2 '23: -153.3K Q3 '23: -342.6K Q4 '23: -92.6K Q1 '24: -109.6K Q2 '24: -70.3K Q3 '24: -73.5K Q4 '24: -127.9K Q1 '25: -167.3K Q2 '25: -73.2K Q3 '25: -49K Q4 '25: -237K Q1 '26: -238.6K Q2 '26: -349.8K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-180K -120K -60K 0 60K 120K 180K Q3 '13: -148.8K Q3 '13

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q2 '20: 97M Q1 '21: 100.1M Q2 '21: 103.4M Q3 '21: 109.9M Q1 '22: 110.8M Q2 '22: 110.8M Q3 '22: 116.4M Q1 '23: 123.5M Q2 '23: 128.8M Q3 '23: 136.4M Q1 '24: 163.4M Q2 '24: 176.6M Q3 '24: 126.4M Q1 '25: 88.8M Q2 '25: 88.8M Q3 '25: 89M Q1 '26: 112.3M Q2 '26: 114.4M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.04 -0.03 -0.01 0.00 0.01 0.03 0.04 Q3 '21: -0.04 Q4 '21: -0.04 Q1 '22: -0.03 Q2 '22: -0.03 Q3 '22: -0.03 Q4 '22: -0.03 Q1 '23: -0.03 Q2 '23: -0.03 Q3 '23: -0.04 Q4 '23: -0.03 Q1 '24: -0.02 Q2 '24: -0.01 Q3 '24: 0.00 Q4 '24: -0.01 Q1 '25: -0.03 Q2 '25: -0.03 Q3 '25: -0.03 Q4 '25: -0.02 Q1 '26: -0.02 Q2 '26: -0.03 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.